Hyperkalemia
Hyperkalemia
Part of NephTimes
Advertisement
Charlotte RobinsonHyperkalemia | September 10, 2024
Hyperkalemia and metabolic acidosis are common with CKD, and the potassium binder SZC may have benefits for both.
Read More
Charlotte RobinsonHyperkalemia | September 9, 2024
Data from DISCOVER CKD was used to assess the burden and real-world treatment of hyperkalemia in CKD patients.
Charlotte RobinsonHyperkalemia | September 3, 2024
A study explored the relationship between intake of dietary fiber and hyperkalemia in patients on maintenance hemodialysis.
Qasim Butt, MD, Medical Consultant and Interventional Nephrologist, Your Kidneys Your HealthHyperkalemia | August 27, 2024
Sponsored content: Qasim Butt, MD, describes the importance of hyperkalemia management and how LOKELMA can help.
Charlotte RobinsonHyperkalemia | September 3, 2024
Researchers assessed the landscape of QSP modeling and developed a use case for QSP to determine hyperkalemia risk.
Charlotte RobinsonHyperkalemia | August 5, 2024
Researchers examined the impact of a local guideline recommending use of SZC in patients with moderate hyperkalemia.
Charlotte RobinsonHyperkalemia | July 19, 2024
The American Kidney Fund introduced guidelines to help patients with chronic kidney disease manage and treat hyperkalemia.
Charlotte RobinsonHyperkalemia | August 9, 2024
Researchers studied the efficacy of a community pharmacist-led nutritional intervention for outpatients with CKD.
Charlotte RobinsonHyperkalemia | August 28, 2024
Could SZC use allow for quick and safe initiation and titration of MRAs and long-term optimal dosing for patients with HRrEF?
Charlotte RobinsonHyperkalemia | July 10, 2024
Authors described the case of a patient with BRASH syndrome-induced atrial fibrillation with a slow ventricular response.
Charlotte RobinsonHyperkalemia | July 9, 2024
What influence does hyperkalemia have on disease severity and mortality risk among patients admitted to the emergency room?
Charlotte RobinsonHyperkalemia | July 8, 2024
Researchers studied how race, ethnicity, and other demographic factors relate to the risk of recurrent hyperkalemia.
Charlotte RobinsonHyperkalemia | June 12, 2024
Transplant recipients often present with characteristics that may be associated with hyperkalemic renal tubular acidosis.
Charlotte RobinsonNKF Spring Clinical Meetings 2024 | May 29, 2024
Pooja Desai discussed a study examining short- vs long-term results of SZC therapy on hyperkalemia-related hospitalization.
Charlotte RobinsonHyperkalemia | April 24, 2024
Research has begun to question recommendations to restrict potassium with CKD to manage hyperkalemia.
Charlotte RobinsonWCN 2024 | April 18, 2024
Researchers studied the prevalence of hyperkalemia in patients at a facility in Durban, South Africa.
Charlotte RobinsonWCN 2024 | May 23, 2024
Researchers reported on real-world use of SZC for hyperkalemia in a cohort of Asian hemodialysis patients.
Charlotte RobinsonHyperkalemia | March 28, 2024
Potassium adsorbents lower serum potassium levels but their effects on mortality and rehospitalization rates were unclear.
Charlotte RobinsonHyperkalemia | March 27, 2024
Researchers sought to determine the palatability of SZC, patiromer, and S/CPS in patients with CKD and hyperkalemia.
Charlotte RobinsonHyperkalemia | March 27, 2024
Experts developed consensus statements for management of hyperkalemia in the Asia–Pacific region.
Advertisement
Advertisement
Advertisement
Latest News

October 8, 2024